Publicações

No Differences in Molecular Relapse-Free Survival After Stopping Imatinib Treatment of Chronic Myeloid Leukemia Between Patients with Prior 4.5 Log Reduction (Mr4.5) but Detectable and Patients with Undetectable Disease in the Euro-Ski Trial

AuthID
P-01B-03A

Author(s)

Pfirrmann, M

Mahon, FX

Guilhot, J

Richter, J

Almeida, A

Janssen, JJWM

Mayer, J

Porkka, K

Panayiotidis, P

Olsson Stromberg, U

Berger, MG

Diamond, J

Ehrencrona, H

Kairisto, V

Polakova, KM

Müller, MC

Mustjoki, S

Hochhaus, A

Saussele, S

Hjorth Hansen, H

Tipo de Documento

Abstract

Year published

2016

Publicado

in BLOOD, ISSN: 0006-4971

Volume: 128, Número: 22, Páginas: 789-789 (5)

Indexing

Wos^®

Crossref^®9

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1182/blood.v128.22.789.789

Wos: WOS:000394446804103

Source Identifiers

ISSN: 0006-4971

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

No Differences in Molecular Relapse-Free Survival After Stopping Imatinib Treatment of Chronic Myeloid Leukemia Between Patients with Prior 4.5 Log Reduction (Mr4.5) but Detectable and Patients with Undetectable Disease in the Euro-Ski Trial

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

No Differences in Molecular Relapse-Free Survival After Stopping Imatinib Treatment of Chronic Myeloid Leukemia Between Patients with Prior 4.5 Log Reduction (Mr4.5) but Detectable and Patients with Undetectable Disease in the Euro-Ski Trial

Links Úteis

Ajuda